These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37908671)

  • 1. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
    Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.
    Chen Y; Shang H; Wang C; Zeng J; Zhang S; Wu B; Cheng W
    Int J Nanomedicine; 2022; 17():105-123. PubMed ID: 35027829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
    Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
    Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
    Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
    Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
    Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy.
    Huang H; Du L; Su R; Li Z; Shao Y; Yuan Y; Wang C; Lu C; He Y; He H; Zhang C
    J Control Release; 2024 Nov; 375():524-536. PubMed ID: 39278356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
    Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
    Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-Responsive Nanodelivery System of GPC3-Targeting and Sonosensitizer for Visualized Hepatocellular Carcinoma Therapy.
    Zhang J; Luo X; Yang X; Li H; Jiang Q; Yang Y; Luo M; Ma Z; He P; Feng L; Li L; Zhang M; Li Y; Yu J
    Int J Nanomedicine; 2024; 19():7015-7031. PubMed ID: 39011387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer.
    Lan M; Zhu L; Wang Y; Shen D; Fang K; Liu Y; Peng Y; Qiao B; Guo Y
    J Nanobiotechnology; 2020 Sep; 18(1):121. PubMed ID: 32883330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
    Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
    Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
    Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering macrophage membrane-camouflaged nanoplatforms with enhanced macrophage function for mediating sonodynamic therapy of ovarian cancer.
    Wang X; Wang H; Li Y; Sun Z; Liu J; Sun C; Cao X
    Nanoscale; 2024 Oct; 16(40):19048-19061. PubMed ID: 39310965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
    Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
    Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
    Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments.
    Qu H; Li L; Chen H; Tang M; Cheng W; Lin TY; Li L; Li B; Xue X
    J Control Release; 2023 Nov; 363():361-375. PubMed ID: 37751826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment.
    Zhang Y; Yuan T; Li Z; Luo C; Wu Y; Zhang J; Zhang X; Fan W
    ACS Biomater Sci Eng; 2021 Apr; 7(4):1515-1525. PubMed ID: 33793187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes.
    Wang D; Wan Z; Yang Q; Chen J; Liu Y; Lu F; Tang J
    Drug Deliv; 2022 Dec; 29(1):702-713. PubMed ID: 35236203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted co-delivery of resiquimod and a SIRPĪ± variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.